A multicentre study of coproxamol poisoning suicides based on coroners' records in England.
暂无分享,去创建一个
D. Gunnell | K. Hawton | L. Sutton | S. Simkin | N. Kapur | P. Turnbull | O. Bennewith | Lesley Sutton | Olive Bennewith
[1] K. Hawton,et al. Value of measuring suicidal intent in the assessment of people attending hospital following self-poisoning or self-injury , 2005, British Journal of Psychiatry.
[2] A. Busuttil,et al. Dextropropoxyphene-related deaths — a problem that persists? , 2005, International Journal of Legal Medicine.
[3] D. Duffy,et al. The National Suicide Prevention Strategy for England , 2003 .
[4] R. Afshari,et al. Co-proxamol and suicide , 2003, BMJ : British Medical Journal.
[5] P. Fryers,et al. Co-proxamol and suicide , 2003, BMJ : British Medical Journal.
[6] J. Deeks,et al. Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings , 2003, BMJ : British Medical Journal.
[7] K. Schapira,et al. Open verdict v. suicide – importance to research , 2001, British Journal of Psychiatry.
[8] K. Hawton,et al. Suicide in older people: mode of death, demographic factors, and medical contact before death , 2000, International journal of geriatric psychiatry.
[9] K. Houston,et al. Suicide in young people , 1999, British Journal of Psychiatry.
[10] I. Chalmers. A symbiosis of paper and electronic publishing, serving the interests of the Journal's readers , 1999, British Journal of Psychiatry.
[11] T. Saldeen,et al. The prevalence of dextropropoxyphene in autopsy blood samples. , 1998, Forensic science international.
[12] K. Hawton,et al. Suicide and stress in farmers , 1998 .
[13] W. Y. Zhang,et al. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol , 1997, BMJ.
[14] Rachel Jenkins,et al. How are nations trying to prevent suicide? An analysis of national suicide prevention strategies , 1997, Acta psychiatrica Scandinavica.
[15] H. Druid,et al. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. , 1997, Journal of forensic sciences.
[16] A. Poklis,et al. Postmortem production of ethanol and factors that influence interpretation: a critical review. , 1996, The American journal of forensic medicine and pathology.
[17] K. Hawton,et al. Paracetamol Self-Poisoning Characteristics, Prevention and Harm Reduction , 1996, British Journal of Psychiatry.
[18] I. Whyte,et al. Correlations between prescriptions and drugs taken in self‐poisoning: Implications for prescribers and drug regulation , 1995, The Medical journal of Australia.
[19] D. Northridge,et al. Dextropropoxyphene Overdose , 1987, Medical toxicology and adverse drug experience.
[20] B. Finkle. Self-poisoning with Dextropropoxyphene and Dextropropoxyphene Compounds: the USA Experience , 1984, Human toxicology.
[21] I. Jones,et al. Fatal Self-poisoning in the UK and the Paracetamol/Dextropropoxyphene Combination , 1984, Human toxicology.
[22] R. M. Whittington. Dextropropoxyphene Deaths: Coroner's Report , 1984, Human toxicology.
[23] K. Breen,et al. Paracetamol self‐poisoning , 1982 .
[24] A. Lawson,et al. Distalgesic poisoning--cause for concern. , 1980, British medical journal.
[25] R. Whittington. Dextropropoxyphene (Distalgesic) overdosage in the West Midlands. , 1977, British medical journal.
[26] E. D. Carson,et al. FATAL DEXTROPROPOXYPHENE POISONING IN NORTHERN IRELAND Review of 30 Cases , 1977, The Lancet.
[27] R. Beck,et al. Suicide notes and risk of future suicide. , 1974, JAMA.
[28] Dean Schuyler,et al. Development of suicidal intent scales. , 1974 .